Definitive Contract 75F40124C00115
Award Date
8/21/24
Potential Completion Date
8/27/28
Potential Value
$2.1M
Federal Agency
Food and Drug Administration
Awardee
Aneon Brillient, LLC
Ultimate Awardee
Not listed
NAICS Category
561110 - Office Administrative Services
PSC Category
R499 - Support- Professional: Other
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Labor Hours
Place of Performance
Calverton, MD 20705, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Food and Drug Administration (FDA) awarded an 8(a) sole source contract to Aneon Brillient, LLC, a minority-owned small disadvantaged business, to provide administrative staffing services for the Center for Drug Evaluation and Research (CDER). The 12-month base contract with a 1-year option period has a ceiling value of $186,092.22 and is a labor-hour type contract. This award demonstrates Aneon Brillient's ongoing support to the FDA, as evidenced by their prior 8(a) sole source...
This is a direct 8(a) sole source award of a 12-month base and 9-month option, labor hour type contract to Aneon Brillient, LLC for the U.S. Food and Drug Administration's (FDA) Center for Drug Evaluation and Research (CDER) to provide professional services. The contract has a ceiling value of $4,277,014.63 and an ultimate completion date of May 31, 2026. Aneon Brillient is a minority-owned, small disadvantaged business certified as an SBA 8(a) joint venture. The company has a history of...
This is a direct 8(a) award of a 12-month, labor-hour type contract to Aneon Brillient, LLC for the U.S. Food and Drug Administration's (FDA) Center for Drug Evaluation and Research (CDER) to provide professional services support. The contract has a ceiling value of $3,266,346.36 and does not utilize a set-aside. Aneon Brillient is a minority-owned, small disadvantaged business registered as an 8(a) joint venture that specializes in providing a range of professional services to the FDA,...
This is a direct 8(a) sole source, labor-hour type contract awarded by the Food and Drug Administration (FDA) to Aneon Brillient, LLC, a minority-owned, small disadvantaged business certified as an 8(a) joint venture. The contract is for professional services to support the FDA's Oncology Center of Excellence, with an ultimate completion date of August 11, 2026 and a ceiling value of $2,220,109.12. Aneon Brillient, LLC specializes in providing a variety of professional services to the FDA,...
This is a $642,543.27 definitive contract awarded by the Food and Drug Administration (FDA) to Aneon Brillient, LLC, an 8(a) certified small disadvantaged business, to provide transcription services to support the Center for Drug Evaluation and Research (CDER) advisory committee meetings. The contract has a completion date of February 27, 2026 and is a sole source award under the 8(a) program. Aneon Brillient specializes in providing professional services to the FDA, including medical and...
This is a definitive contract awarded by the U.S. Food and Drug Administration (FDA) to Aneon Brillient, LLC, a Small Business Administration (SBA) certified 8(a) joint venture, for $326,304.48. The contract provides shipping, receiving, printing support, and administrative support services for the FDA's Office of Regulatory Affairs Office of Training, Education, and Development (OTED). The contract is set aside for 8(a) small businesses and has a performance period ending on September 29, 2026....
This award represents a 1-year, $190,357.34 time and materials contract for information technology professional services awarded by the U.S. Food and Drug Administration's (FDA) Center for Drug Evaluation and Research (CDER) to Aneon Brillient, LLC, an SBA-certified 8(a) joint venture. The contract supports the Office of Pharmaceutical Quality within CDER. As an 8(a) sole source award, this contract leverages the SBA's business development program to provide specialized IT services to the FDA....
This is a 3-year, labor-hour contract for $3,120,771.46 awarded by the U.S. Food and Drug Administration (FDA), Center for Devices and Radiological Health (CDRH), Office of to Aneon Brillient, LLC, an SBA-certified 8(a) joint venture, for communication, administrative, and information disclosure support services. The contract is a direct 8(a) sole source award, leveraging Aneon Brillient's 8(a) status. Aneon Brillient is a minority-owned, small disadvantaged business that provides professional...
This is a $144,964.92 sole source 8(a) contract awarded by the Food and Drug Administration (FDA) to Aneon Brillient, LLC, a minority-owned small disadvantaged business. The contract is for additive manufacturing of medical products core facility support, on a labor-hour basis. Aneon Brillient is an SBA-certified 8(a) joint venture that specializes in providing professional services to the FDA, including across the Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation...
This is a $192,142.38 firm fixed-price purchase order awarded by the U.S. Food and Drug Administration (FDA) to Aneon Brillient, LLC, a minority-owned small disadvantaged business certified as an 8(a) joint venture. The contract is for a Quality Assurance Specialist III position to support the FDA's Center for Drug Evaluation and Research (CDER) and Office of Pharmaceutical Quality (OPQ). The work will be performed in Calverton, Maryland and has an ultimate completion date of August 29, 2025....